Lapi, Francesco
Marconi, Ettore
Aprile, Pierangelo Lora
Rossi, Alessandro
Fornasari, Diego
Cricelli, Claudio
Funding for this research was provided by:
Angelini Pharma,Italy
Article History
Received: 20 November 2023
Accepted: 8 February 2024
First Online: 17 February 2024
Declarations
:
: FL and EM provided consultancies in protocol preparation for epidemiological studies and data analyses for Angelini, Dompè, GSK and Viatris. PLA, AR and CC provided clinical consultancies for Angelini, Dompè, GSK and Viatris. The other authors have no conflicts of interest to disclose.
: The funder had no role in the design and execution of this study as well as in analyses, interpretation of the data, and manuscript submission.